Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT
Authors:
- 17 April 2012
- journal article
- case report
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 47 (9) , 1036-1047
Abstract
We aimed to evaluate gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) for the detection of hepatocellular carcinomas (HCCs) and dysplastic nodules (DNs) compared with dynamic multi-detector row computed tomography (MDCT), and to discriminate between HCCs and DNs.Keywords
This publication has 24 references indexed in Scilit:
- Detection of Hepatocellular CarcinomaJournal of Computer Assisted Tomography, 2009
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia # †Hepatology, 2009
- Multistep human hepatocarcinogenesis: correlation of imaging with pathologyJournal of Gastroenterology, 2009
- Candidate Molecular Markers for Histological Diagnosis of Early Hepatocellular CarcinomaIntervirology, 2008
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of HepatologyOncology, 2007
- Liver Tumor CharacterizationJournal of Computer Assisted Tomography, 2006
- Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance imagesJournal of Gastroenterology, 2005
- Imaging of Dysplastic Nodules and Small Hepatocellular Carcinomas: Experience with Explanted LiversIntervirology, 2004
- Imaging Diagnosis of Hepatocellular Carcinoma and Premalignant/Borderline LesionsSeminars in Liver Disease, 1999
- Terminology of nodular hepatocellular lesionsHepatology, 1995